SWAYZE ERIC (SVP, Research) sold 32.8% of their position (10.60K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $839.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0000874015-26-000211
Officer· SVP, Research
Since Jan 2020
-10.60K
Net shares
Net seller
$839.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.60K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.60K
Price / share
$79.18
Trade value
$839.49K
% of position
32.8%
6/25/2026
32.36K→21.76K
Total
Net shares
−10.60K
Net value
-$839.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | S · Sale | −10.60K | $79.18 | $839.49K | 32.8% | 32.36K | 21.76K |
| Total | −10.60K | -$839.49K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned318.00
Total
318.00 indirect318.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 318.00 | Indirect |
| Total | 318.00 | 318.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported